JP2017529322A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017529322A5 JP2017529322A5 JP2017505548A JP2017505548A JP2017529322A5 JP 2017529322 A5 JP2017529322 A5 JP 2017529322A5 JP 2017505548 A JP2017505548 A JP 2017505548A JP 2017505548 A JP2017505548 A JP 2017505548A JP 2017529322 A5 JP2017529322 A5 JP 2017529322A5
- Authority
- JP
- Japan
- Prior art keywords
- moiety
- polymer
- integer
- substituted
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462031382P | 2014-07-31 | 2014-07-31 | |
| US62/031,382 | 2014-07-31 | ||
| PCT/US2015/043297 WO2016019340A1 (en) | 2014-07-31 | 2015-07-31 | Polyoxazoline antibody drug conjugates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017529322A JP2017529322A (ja) | 2017-10-05 |
| JP2017529322A5 true JP2017529322A5 (enExample) | 2018-08-30 |
| JP6704900B2 JP6704900B2 (ja) | 2020-06-03 |
Family
ID=55178936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017505548A Active JP6704900B2 (ja) | 2014-07-31 | 2015-07-31 | ポリオキサゾリン抗体薬物複合体 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10071168B2 (enExample) |
| EP (1) | EP3180388A4 (enExample) |
| JP (1) | JP6704900B2 (enExample) |
| KR (1) | KR20170046141A (enExample) |
| CN (1) | CN106715533B (enExample) |
| CA (1) | CA2956709A1 (enExample) |
| WO (1) | WO2016019340A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018112551A1 (en) * | 2016-12-23 | 2018-06-28 | Commonwealth Scientific And Industrial Research Organisation | Biocompatible and hydrophilic polymer conjugate for targeted delivery of an agent |
| US20220411463A1 (en) * | 2019-03-18 | 2022-12-29 | Khashayar Karimian | Mate and separate: a convenient and general method for the separation and purification of target molecules from biological media by phase transition of pegylated recognition agents. |
| WO2020247151A1 (en) * | 2019-06-05 | 2020-12-10 | Boston Scientific Scimed, Inc. | Click chemistry capturable platinum-based antineoplastic agents |
| EP4395748A1 (en) | 2021-09-03 | 2024-07-10 | CureVac SE | Novel lipid nanoparticles for delivery of nucleic acids |
| US20240398933A1 (en) | 2021-09-03 | 2024-12-05 | CureVac SE | Novel lipid nanoparticles for delivery of nucleic acids comprising phosphatidylserine |
| US20250027108A1 (en) | 2021-10-29 | 2025-01-23 | CureVac SE | Improved circular rna for expressing therapeutic proteins |
| US20230322996A1 (en) * | 2021-11-08 | 2023-10-12 | Life Technologies As | Polymer-interaction molecule conjugates and methods of use |
| EP4469091A1 (en) | 2022-01-28 | 2024-12-04 | CureVac SE | Nucleic acid encoded transcription factor inhibitors |
| US20250288682A1 (en) * | 2022-04-26 | 2025-09-18 | University Of Virginia Patent Foundation | Development of nano-encapsulated fatty-acyl conjugated colchicine |
| AU2024233180A1 (en) | 2023-03-08 | 2025-09-25 | CureVac SE | Novel lipid nanoparticle formulations for delivery of nucleic acids |
| WO2024230934A1 (en) | 2023-05-11 | 2024-11-14 | CureVac SE | Therapeutic nucleic acid for the treatment of ophthalmic diseases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8871720B2 (en) | 2005-07-07 | 2014-10-28 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus |
| US20140011964A1 (en) * | 2007-02-28 | 2014-01-09 | Serina Therapeutics, Inc. | Activated Polyoxazolines and Conjugates and Compositions Comprising the Same |
| EP2134181A4 (en) * | 2007-02-28 | 2011-09-28 | Serina Therapeutics Inc | ACTIVATED POLYOXAZOLINES AND COMPOSITION COMPRISING THE SAME |
| US8101706B2 (en) | 2008-01-11 | 2012-01-24 | Serina Therapeutics, Inc. | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same |
| EP3042922B1 (en) | 2008-01-11 | 2017-07-19 | Serina Therapeutics, Inc. | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same |
| AU2009292643B2 (en) | 2008-09-19 | 2016-02-18 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
| WO2011130598A1 (en) * | 2010-04-15 | 2011-10-20 | Spirogen Limited | Pyrrolobenzodiazepines and conjugates thereof |
| WO2013020005A2 (en) * | 2011-08-03 | 2013-02-07 | Anp Technologies, Inc. | Oxazoline polymer compositions and use thereof |
| US8383093B1 (en) | 2011-11-01 | 2013-02-26 | Serina Therapeutics, Inc. | Subcutaneous delivery of poly(oxazoline) conjugates |
-
2015
- 2015-07-31 CN CN201580052259.3A patent/CN106715533B/zh active Active
- 2015-07-31 EP EP15826412.7A patent/EP3180388A4/en not_active Withdrawn
- 2015-07-31 WO PCT/US2015/043297 patent/WO2016019340A1/en not_active Ceased
- 2015-07-31 KR KR1020177005598A patent/KR20170046141A/ko not_active Withdrawn
- 2015-07-31 US US14/815,718 patent/US10071168B2/en active Active
- 2015-07-31 JP JP2017505548A patent/JP6704900B2/ja active Active
- 2015-07-31 CA CA2956709A patent/CA2956709A1/en not_active Abandoned
-
2018
- 2018-09-10 US US16/126,798 patent/US11065340B2/en active Active